COMMUNIQUÉS West-GlobeNewswire
-
CorVel Announces Revenues and Earnings
20/05/2026 -
Disclosure of voting rights at AGM in Vistin Pharma ASA
20/05/2026 -
Winner Medical Breaks Ground on New Production Base in Vietnam to Serve Global Medical Supply Chains Through Local Manufacturing
20/05/2026 -
Un essai clinique canadien sans précédent évalue des « comprimés de selles » pour améliorer l’immunothérapie du cancer du poumon
20/05/2026 -
Synendos Therapeutics Starts Phase 2 Trial in Generalized Anxiety Disorder
20/05/2026 -
IBA launches Rhodotron® LITE, a new low‑power X‑ray accelerator expanding access to sustainable irradiation solutions
20/05/2026 -
IBA lance Rhodotron® LITE, un nouvel accélérateur à rayons X de faible puissance qui facilite l’accès à des solutions d’irradiation durables
20/05/2026 -
SERB Pharmaceuticals acquiert auprès de Hansa Biopharma les droits européens et MENA d’Idefirix® (imlifidase) pour 115 millions d’euros
20/05/2026 -
Shiny Smile Veneers Claims Evaluated (2026 Consumer Report Update) Critical Complaints Investigated
20/05/2026 -
SlimTide Claims Evaluated: The Baking Soda Water Shot Gelatin Trick for Losing Weight Naturally by Slim Tide
20/05/2026 -
Java Tide Critical Assessment: The Gelatin Ice Trick Before Bed Using the Java Tide Formula Recipe
20/05/2026 -
Ipsen announces late-breaking data from first head-to-head study comparing Dysport® and Botox® in adults with upper limb spasticity
19/05/2026 -
NurExone Receives Notice of Patent Grant in South Korea Covering ExoPTEN Technology
19/05/2026 -
Iridex Reports First Quarter 2026 Financial Results
19/05/2026 -
Kura Oncology to Present at TD Cowen 7th Annual Oncology Innovation Summit
19/05/2026 -
Vaxart Files Preliminary Proxy Statement and Issues Open Letter to Shareholders
19/05/2026 -
Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at EULAR 2026 Congress, Including Late-Breaking Oral Presentation Highlighting Clinical Efficacy Comparable to Autologous CAR T-Cell Therapy in Rheumatologic Diseases
19/05/2026 -
Relay Therapeutics Announces Proposed Public Offering of Common Stock
19/05/2026 -
Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition
19/05/2026
Pages